IMPACT HEALTHCARE REIT PLC
(the "Company")
PDMR Notification
1 February 2024
The Company, announces that on 31 January 2024, Amanda Aldridge, Non-Executive Director of the Company, acquired 20,000 ordinary shares in the Company ("Ordinary Shares").
Following the above acquisition of shares, Amanda Aldridge holds 20,000 Ordinary Shares in the Company, representing approximately 0.0048% of the Company's issues Ordinary Share Capital.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")
| |||||
| a)
| Name
| Amanda Aldridge | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| PDMR Non-Executive Director | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Impact Healthcare REIT PLC | ||||
| b)
| LEI
| 213800AX3FHPMJL4IJ53 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares
ISIN: GB00BYXVMJ03 | ||||
| b)
| Nature of the transaction | Purchase
| ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price |
20,000 ordinary shares in aggregate
£17,293.20 | ||||
| e)
| Date of the transaction
| 31/01/2024
| ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
By order of the Board
Impact Healthcare REIT PLC
| JTC (UK) Limited - Company Secretary Christopher Gibbons |
+44 (0) 203 846 9774 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.